Lise Pedersen1, Susanne Møller Pedersen2, Claus Lohman Brasen3, Lars Melholt Rasmussen2. 1. Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark. Electronic address: Lise-Pedersen@ouh.regionsyddanmark.dk. 2. Department of Clinical Biochemistry and Pharmacology, Odense University Hospital, Odense, Denmark. 3. Department of Clinical Biochemistry, Vejle Hospital, Denmark.
Abstract
OBJECTIVE: Soluble serum Klotho is a new biomarker linked to chronic kidney disease, cardiovascular disease and diabetes. This study describes the evaluation and comparison of two different immunoassays and establishment of assay specific reference intervals in adults. DESIGN AND METHODS: Serum Klotho concentrations were determined in 120 healthy adults aged 19-66 years. Blood samples were collected, and stored sera were assayed for Klotho according to age and gender. In addition several other clinical and laboratory characteristics were determined in the cohort and compared to the levels of serum Klotho. RESULTS: Serum Klotho levels were significantly higher in time-resolved fluorescence immunoassay (TRF) compared to an ELISA (IBL) and no correlation was found between the assays. No signal was obtained in either assay when the standard curve was switched between the two different immunoassays. The median serum Klotho concentration using TRF was 61 ng/mL (2.5-97.5% reference limits; 11-181 ng/mL) for males and 99 ng/mL (2.5-97.5% reference limits; 19-316 ng/mL) for females while the ELISA gave a mean value of 472 pg/mL (2.5-97.5% reference limits; 204-741 pg/mL) with no difference between genders. Concentrations of serum Klotho were independently associated with estimated glomerular filtration rate (eGFR) and body weight using TRF whereas serum Klotho concentrations were associated with age using the ELISA. CONCLUSION: Comparison of two different immunoassays for serum Klotho indicate, that the protein exists in human beings in different forms which may function as independent factors and whose role and potential value as biomarkers needs to be evaluated separately. Reference intervals specific for the different forms recognized by the different assays were calculated in this study. Crown
OBJECTIVE: Soluble serum Klotho is a new biomarker linked to chronic kidney disease, cardiovascular disease and diabetes. This study describes the evaluation and comparison of two different immunoassays and establishment of assay specific reference intervals in adults. DESIGN AND METHODS: Serum Klotho concentrations were determined in 120 healthy adults aged 19-66 years. Blood samples were collected, and stored sera were assayed for Klotho according to age and gender. In addition several other clinical and laboratory characteristics were determined in the cohort and compared to the levels of serum Klotho. RESULTS: Serum Klotho levels were significantly higher in time-resolved fluorescence immunoassay (TRF) compared to an ELISA (IBL) and no correlation was found between the assays. No signal was obtained in either assay when the standard curve was switched between the two different immunoassays. The median serum Klotho concentration using TRF was 61 ng/mL (2.5-97.5% reference limits; 11-181 ng/mL) for males and 99 ng/mL (2.5-97.5% reference limits; 19-316 ng/mL) for females while the ELISA gave a mean value of 472 pg/mL (2.5-97.5% reference limits; 204-741 pg/mL) with no difference between genders. Concentrations of serum Klotho were independently associated with estimated glomerular filtration rate (eGFR) and body weight using TRF whereas serum Klotho concentrations were associated with age using the ELISA. CONCLUSION: Comparison of two different immunoassays for serum Klotho indicate, that the protein exists in human beings in different forms which may function as independent factors and whose role and potential value as biomarkers needs to be evaluated separately. Reference intervals specific for the different forms recognized by the different assays were calculated in this study. Crown
Authors: Javier Donate-Correa; Ernesto Martín-Núñez; Carmen Mora-Fernández; Mercedes Muros-de-Fuentes; Nayra Pérez-Delgado; Juan F Navarro-González Journal: World J Biol Chem Date: 2015-11-26
Authors: Ella Zeldich; Ci-Di Chen; Emma Boden; Bryce Howat; Jason S Nasse; Dean Zeldich; Anthony G Lambert; Andrea Yuste; Jonathan D Cherry; Rebecca M Mathias; Qicheng Ma; Nelson C Lau; Ann C McKee; Theo Hatzipetros; Carmela R Abraham Journal: J Mol Neurosci Date: 2019-06-27 Impact factor: 3.444
Authors: Didier Chalhoub; Elisa Marques; Osorio Meirelles; Richard D Semba; Luigi Ferrucci; Suzanne Satterfield; Michael Nevitt; Jane A Cauley; Tamara Harris Journal: J Am Geriatr Soc Date: 2016-12-02 Impact factor: 5.562
Authors: Jarrod W Barnes; Dawn Duncan; Scott Helton; Samuel Hutcheson; Deepali Kurundkar; Naomi J Logsdon; Morgan Locy; Jaleesa Garth; Rebecca Denson; Carol Farver; Hai T Vo; Gwendalyn King; Dominik Kentrup; Christian Faul; Tejaswini Kulkarni; Joao A De Andrade; Zhihong Yu; Sadis Matalon; Victor J Thannickal; Stefanie Krick Journal: Am J Physiol Lung Cell Mol Physiol Date: 2019-05-01 Impact factor: 5.464